Articles tagged "Infection"

2020 American Transplant Congress
Effect of Rituximab Dose as Induction Therapy in ABO Incompatible Living Kidney Transplantation A Systemic Review and Network Meta Analysis
S. Hwang¹, W. Park², K. Kim¹, S. Lee¹, J. Song¹
¹Inha University, Incheon, Korea, Republic of, ²Keimyung University, Daegu, Korea, Republic of
*Purpose: ABO-incompatible living kidney transplantation (ABOILKT) has steadily become more widespread. However, the optimal immunosuppressive regimen for ABOILKT remains uncertain. We aimed to determine the…
2020 American Transplant Congress
Characteristics of Kidney Transplant Patients Diagnosed with Histoplasmosis
C. Miles, J. Hall, S. Westphal, E. Langewisch
University of Nebraska Medical Center, Omaha, NE
*Purpose: Histoplasmosis is responsible for the greatest number of hospitalizations and deaths due to endemic mycoses in the United States. Although lying near the western…
2020 American Transplant Congress
Evaluation of Intraoperative versus Extended Antibiotic Prophylaxis in Liver Transplantation
S. Hamel¹, C. Garza¹, C. Gamble², H. Boone³, L. Thomas⁴, D. L. Gorden⁵
¹Pharmacy, Vanderbilt University Medical Center, Nashville, TN, ²Quality, Vanderbilt Transplant Center, Nashville, TN, ³Vanderbilt University Medical Center, Nashville, TN, ⁴Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, ⁵Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Perioperative antibiotic use has important implications for patient care, antimicrobial stewardship, and cost containment. There is limited data guiding the optimal duration of perioperative…
2020 American Transplant Congress
Reduced Dose Valganciclovir is Effective for CMV Prevention without Excess Breakthrough or Resistance in Kidney Transplantation
M. Luu¹, P. Klem¹, B. Crowther¹, M. Abidi², M. Miller¹, K. Schoeppler¹, S. Davis²
¹Pharmacy, University of Colorado Hospital, Aurora, CO, ²Medicine, University of Colorado, Aurora, CO
*Purpose: Reduced dose valganciclovir (VGC) (450 mg daily) may be a useful alternative to full dose VGC for cytomegalovirus (CMV) prophylaxis due to drug cost…
2020 American Transplant Congress
The Association between Infection and Important Clinical Outcomes in Acute-On-Chronic Liver Patients Admitted to ICU: A Single Center Cohort Analysis
M. Kim¹, A. Pawlowski², R. G. Wunderink³, D. P. Ladner⁴, C. J. Karvellas⁵
¹Neurology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Medicine, Northwestern University, Chicago, IL, ⁴Surgery, Northwestern University, Chicago, IL, ⁵Medicine, University of Alberta, Edmonton, AB, Canada
*Purpose: One of the most common precipitants of acute on chronic liver failure (ACLF) in cirrhotic patients is sepsis. We aimed to evaluate the relationship…
2020 American Transplant Congress
Adenovirus Infection in Kidney Transplant Recipients: A Case Series
S. Anjan, Y. Natori, M. Raja, J. Camargo, J. Simkins, M. Morris, A. Fernandez, G. Ciancio, L. Chen, G. Burke, M. Ortigosa-Goggins, J. Pagan, A. Mattiazzi, G. Guerra, L. Abbo
University of Miami/Jackson Memorial Hospital, Miami, FL
*Purpose: Adenovirus (AdV) is associated with poor outcomes in immunosuppressed patients and data on incidence and management in kidney transplant (KT) recipients is limited. *Methods:…
2020 American Transplant Congress
Efficacy and Tolerability of Tedizolid Phosphate in the Treatment of Mycobacterium Abscessus Infection among Pediatric Hematopoietic Stem Cell Transplant Recipients
Y. Kang, V. M. Aquino, A. Y. Koh, D. Wetzel, P. K. Sue
Pediatrics, UT Southwestern Medical Center, Dallas, TX
*Purpose: Mycobacterium abscessus complex infections are associated with high rates of morbidity and mortality in immunocompromised hosts. Treatment can be challenging due to broad spectrum…
2020 American Transplant Congress
Treatment of BK Viremia in Kidney Transplant Recipients: A Single-Center Experience
M. Chaung, E. Hollinger, M. Brokhof, N. Kenyon, L. Lineberger, N. Alvey
Rush University Medical Center, Chicago, IL
*Purpose: Over the past 10 years, our center has utilized various strategies in managing BK viremia in our kidney transplant recipients. Reducing immunosuppression (IMS) in…
2020 American Transplant Congress
Evaluation Of Typical Renal Transplant Infections In Simultaneous Heart-kidney Transplant Recipients
E. J. Henricksen¹, U. Wang¹, R. Lee¹, R. Imai¹, A. Puing², A. Couture², A. Multani³, Y. Moayedi⁴, C. Lenihan⁵, K. K. Khush⁶, J. J. Teuteberg⁵
¹Pharmacy, Stanford Healthcare, Stanford, CA, ²Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, ³Infectious Diseases, UCLA, Los Angeles, CA, ⁴Cardiology, University Health Network, Toronto, ON, Canada, ⁵Department of Medicine, Stanford University, Stanford, CA, ⁶Medicine, Stanford University, Stanford, CA
*Purpose: Simultaneous heart-kidney transplant (SHKT) is an increasingly utilized treatment for patients with end stage heart failure and advanced kidney disease. Data regarding infectious complications…
2020 American Transplant Congress
The Risks Associated with Blood Transfusions in Kidney Transplant Recipients: A Retrospective Cohort Study Using Health Administrative Data
D. Massicotte-Azarniouch¹, M. Sood², D. Fergusson³, M. Chassé⁴, A. Tinmouth⁵, G. Knoll⁶
¹Medicine, University of Ottawa, Ottawa Hospital, Ottawa, ON, Canada, ²Medicine, University of Ottawa, Ottawa Hospital Research Insitute, Ottawa, ON, Canada, ³Clinical Epidemiology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ⁴Medicine, University of Montreal, Montreal, QC, Canada, ⁵Hematology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ⁶Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada
*Purpose: Red blood cell transfusion (RBCT) is a common occurrence in kidney transplant recipients, however it may carry certain risks which could be detrimental to…